SurvivorNet on MSN
FDA Approves New Subcutaneous (Under-the-Skin) Option for Keytruda: What It Means for Cancer Patients
The U.S. Food and Drug Administration (FDA) has approved the subcutaneous form of Keytruda for a new 'Under-the-Skin' Option for patients. The subcutaneous form of Keytruda showed to deliver the same ...
The FDA approves Forzinity (elamipretide HCl) to improve muscle strength in adult and pediatric patients with Barth syndrome weighing at least 30kg.
The FDA has expanded the approval of Tremfya (guselkumab) for the treatment of adults with moderately to severely active ulcerative colitis (UC) to include an SC induction regimen.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback